多发性硬化症静脉成形术的安全性与有效性:一项随机、双盲、假手术对照的II期试验
该随机双盲假手术对照II期试验纳入104例复发型或进展型多发性硬化症患者,比较球囊静脉成形术与假手术对颅外颈静脉和奇静脉狭窄的疗效。结果显示两组在48周内的不良事件和MSQOL-54评分变化上无显著差异,数据不支持继续使用静脉成形术改善患者报告结局、慢性症状或疾病进程。
要点
- 球囊静脉成形术与假手术在48周不良事件数量上无显著差异。
- MSQOL-54生理评分变化两组间无显著差异(p=0.95)。
- MSQOL-54心理评分变化两组间无显著差异(p=0.55)。
核心结论
- 数据不支持继续使用颅外颈静脉和/或奇静脉狭窄的静脉成形术来改善患者报告结局、慢性多发性硬化症症状或疾病进程。
研究设计与样本
- 随机、双盲、假手术对照的II期试验,纳入104例复发型或进展型多发性硬化症患者,经静脉造影确认狭窄>50%后按1:1随机接受球囊或假手术静脉成形术,随访48周。
主要发现
- 104例参与者被随机分组(55例假手术;49例静脉成形术),103例完成48周随访。
- 23例假手术和21例静脉成形术参与者报告至少1次不良事件;1例假手术(2%)和5例(10%)静脉成形术参与者发生严重不良事件。
- MSQOL-54生理评分平均改善:假手术组+1.3,静脉成形术组+1.4(p=0.95)。
- MSQOL-54心理评分平均变化:假手术组+1.2,静脉成形术组-0.8(p=0.55)。
关键数值与推荐
- 主要安全性结局为48周内不良事件数量。
- 主要有效性结局为从基线至第48周患者报告结局MSQOL-54问卷的变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the safety and efficacy of balloon vs sham venoplasty of narrowing of the extracranial jugular and azygos veins in multiple sclerosis (MS). METHODS: Patients with relapsing or progressive MS were screened using clinical and ultrasound criteria. After confirmation of >50% narrowing by venography, participants were randomized 1:1 to receive balloon or sham venoplasty of all stenoses and were followed for 48 weeks. Participants and research staff were blinded to intervention allocation. The primary safety outcome was the number of adverse events (AEs) during 48 weeks. The primary efficacy outcome was the change from baseline to week 48 in the patient-reported outcome MS Quality of Life-54 (MSQOL-54) questionnaire. Standardized clinical and MRI outcomes were also evaluated. RESULTS: One hundred four participants were randomized (55 sham; 49 venoplasty) and 103 completed 48 weeks of follow-up. Twenty-three sham and 21 venoplasty participants reported at least 1 AE; one sham (2%) and 5 (10%) venoplasty participants had a serious AE. The mean improvement in MSQOL-54 physical score was +1.3 (sham) and +1.4 (venoplasty) (p = 0.95); MSQOL-54 mental score was +1.2 (sham) and -0.8 (venoplasty) (p = 0.55). CONCLUSIONS: Our data do not support the continued use of venoplasty of extracranial jugular and/or azygous venous narrowing to improve patient-reported outcomes, chronic MS symptoms, or the disease course of MS. CLINICALTRIALSGOV IDENTIFIER: NCT01864941. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that for patients with MS, balloon venoplasty of extracranial jugular and azygous veins is not beneficial in improving patient-reported, standardized clinical, or MRI outcomes.
引用
- Traboulsee AL, Machan L, Girard JM, et al. Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial. Neurology. 2018. PMID: 30266886. doi:10.1212/WNL.0000000000006423
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。